Insider · CIK 0001354718

Halak Brian K

Reports to the SEC for 29 companies · PRINCETON, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001354718

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2023-01-04	ALIMERA SCIENCES INCStock Option (Right to Buy)A Award	Director	AAward	+6,000 sh	—	—	6,000
2021-11-02	ALIMERA SCIENCES INCStock Option (Right to Buy)A Award	Director	AAward	+6,000 sh	—	—	6,000
2021-09-17	ALIMERA SCIENCES INCJ Other	Director	JOther	+215 sh	—	—	327
2020-06-18	ALIMERA SCIENCES INCStock Option (Right to Buy)A Award	Director	AAward	+3,333 sh	—	—	3,333
2019-06-19	ALIMERA SCIENCES INCStock Option (Right to Buy)A Award	Director	AAward	+50K sh	—	—	50,000
2018-11-06	Dicerna Pharmaceuticals IncS Sale	Director	SSale	−761 sh	$13.18	−$10K	19,161
2018-11-06	Dicerna Pharmaceuticals IncS Sale	Director	SSale	−1,489 sh	$14.16	−$21.1K	2,586,535
2018-11-06	Dicerna Pharmaceuticals IncS Sale	Director	SSale	−102K sh	$13.18	−$1.35M	2,588,024
2018-11-06	Dicerna Pharmaceuticals IncS Sale	Director	SSale	−11 sh	$14.16	−$155.76	19,150
2018-11-05	Dicerna Pharmaceuticals IncS Sale	Director	SSale	−295 sh	$12.98	−$3,829.1	19,922
2018-11-05	Dicerna Pharmaceuticals IncS Sale	Director	SSale	−39.6K sh	$12.98	−$514K	2,690,091
2018-11-02	Dicerna Pharmaceuticals IncS Sale	Director	SSale	−1,412 sh	$13.47	−$19K	20,217
2018-11-02	Dicerna Pharmaceuticals IncS Sale	Director	SSale	−189K sh	$13.47	−$2.55M	2,729,697
2018-11-01	Dicerna Pharmaceuticals IncS Sale	Director	SSale	−1,408 sh	$13.37	−$18.8K	21,629
2018-11-01	Dicerna Pharmaceuticals IncS Sale	Director	SSale	−1,408 sh	$13.37	−$18.8K	21,629
2018-11-01	Dicerna Pharmaceuticals IncS Sale	Director	SSale	−189K sh	$13.37	−$2.53M	2,919,056
2018-11-01	Dicerna Pharmaceuticals IncS Sale	Director	SSale	−188K sh	$13.37	−$2.52M	2,919,056
2018-10-31	Dicerna Pharmaceuticals IncS Sale	Director	SSale	−129K sh	$13.60	−$1.75M	3,107,923
2018-10-31	Dicerna Pharmaceuticals IncS Sale	Director	SSale	−129K sh	$13.60	−$1.75M	3,107,923
2018-10-31	Dicerna Pharmaceuticals IncS Sale	Director	SSale	−959 sh	$13.60	−$13K	23,037
2018-10-31	Dicerna Pharmaceuticals IncS Sale	Director	SSale	−959 sh	$13.60	−$13K	23,037
2018-10-30	Dicerna Pharmaceuticals IncS Sale	Director	SSale	−90.9K sh	$14.31	−$1.3M	3,236,593
2018-10-30	Dicerna Pharmaceuticals IncS Sale	Director	SSale	−678 sh	$14.31	−$9,702.18	23,996
2018-10-30	Dicerna Pharmaceuticals IncS Sale	Director	SSale	−1,136 sh	$13.68	−$15.5K	24,674
2018-10-30	Dicerna Pharmaceuticals IncS Sale	Director	SSale	−152K sh	$13.68	−$2.08M	3,327,511
2018-10-30	Dicerna Pharmaceuticals IncS Sale	Director	SSale	−90.9K sh	$14.31	−$1.3M	3,236,593
2018-10-30	Dicerna Pharmaceuticals IncS Sale	Director	SSale	−1,136 sh	$13.68	−$15.5K	24,674
2018-10-30	Dicerna Pharmaceuticals IncS Sale	Director	SSale	−678 sh	$14.31	−$9,702.18	23,996
2018-10-30	Dicerna Pharmaceuticals IncS Sale	Director	SSale	−152K sh	$13.68	−$2.08M	3,327,511
2018-06-21	Dicerna Pharmaceuticals IncStock Option (Right to Buy)A Award	Director	AAward	+25K sh	—	—	25,000
2018-06-19	ALIMERA SCIENCES INCStock Option (Right to Buy)A Award	Director	AAward	+40K sh	—	—	40,000
2018-06-07	Dicerna Pharmaceuticals IncWarrant to Purchase Common StockM Exercise/Conversion	Director	MExercise/Conversion	−156 sh	—	—	0
2018-06-07	Dicerna Pharmaceuticals IncWarrant to Purchase Common StockM Exercise/Conversion	Director	MExercise/Conversion	−21K sh	—	—	0
2018-06-07	Dicerna Pharmaceuticals IncF Tax Payment	Director	FTax Payment	−76 sh	$14.45	−$1,098.2	25,810
2018-06-07	Dicerna Pharmaceuticals IncM Exercise/Conversion	Director	MExercise/Conversion	+156 sh	$7.00	+$1,092	25,886
2018-06-07	Dicerna Pharmaceuticals IncF Tax Payment	Director	FTax Payment	−10.2K sh	$14.45	−$147K	3,479,875
2018-06-07	Dicerna Pharmaceuticals IncM Exercise/Conversion	Director	MExercise/Conversion	+21K sh	$7.00	+$147K	3,490,070
2017-07-18	Dicerna Pharmaceuticals IncStock Option (Right to Buy)A Award	Director	AAward	+25K sh	—	—	25,000
2017-06-22	ALIMERA SCIENCES INCStock Option (Right to Buy)A Award	Director	AAward	+40K sh	—	—	40,000
2016-06-23	ALIMERA SCIENCES INCStock Option (Right to Buy)A Award	Director	AAward	+20K sh	—	—	20,000
2016-06-14	Dicerna Pharmaceuticals IncStock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2015-07-16	ALIMERA SCIENCES INCJ Other	Director	JOther	+1,692 sh	—	—	1,692
2015-06-25	Dicerna Pharmaceuticals IncStock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2015-06-25	ALIMERA SCIENCES INCStock Option (Right to Buy)A Award	Director	AAward	+20K sh	—	—	20,000
2014-03-19	CADENCE PHARMACEUTICALS INCD Disposition to Issuer	10% Owner	DDisposition to Issuer	−27.5K sh	$14.00	−$385K	0
2014-03-19	CADENCE PHARMACEUTICALS INCD Disposition to Issuer	10% Owner	DDisposition to Issuer	−2.97M sh	$14.00	−$41.6M	0
2014-03-19	CADENCE PHARMACEUTICALS INCD Disposition to Issuer	10% Owner	DDisposition to Issuer	−50.7K sh	$14.00	−$710K	0
2014-03-17	Achaogen, Inc.C Conversion	10% Owner	CConversion	+1.99M sh	—	—	1,987,049
2014-03-17	Achaogen, Inc.C Conversion	10% Owner	CConversion	+33.9K sh	—	—	33,890
2014-03-17	Achaogen, Inc.Series B Preferred StockC Conversion	10% Owner	CConversion	−625K sh	—	—	0

Recent filings

Accepted (ET)
Jan 64
Halak Brian K0001474506-23-000012
SEC(opens sec.gov)
Nov 44
Halak Brian K0001474506-21-000163
SEC(opens sec.gov)
Sep 174
Halak Brian K0000904454-21-000668
SEC(opens sec.gov)
Jun 224
Halak Brian K0000904454-20-000413
SEC(opens sec.gov)
Jun 214
Halak Brian K0000904454-19-000515
SEC(opens sec.gov)
Nov 64
Halak Brian K0000904454-18-000702
SEC(opens sec.gov)
Nov 54/A
Halak Brian K0000904454-18-000697
SEC(opens sec.gov)

Companies

Address

C/O DOMAIN ASSOCIATES, LLC ONE PALMER SQUARE

PRINCETON, NJ, 08542